Heartland Group Holdings stock gets a merger CEO designate appointment

Published on 10/08/2026 at 06:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Heartland Group Holdings stock was last at NZD 1.22 on October 8, 2026, while the proposed NZD 620 million TSB merger advances. FY2026 revenue rose 29.8 percent.

HGH, NZHGHE0007S9, Illustration mit AI erstellt.

Heartland Group Holdings stock (ISIN NZHGHE0007S9) was last at NZD 1.22 on the NZX on October 8, 2026 at 4:40 p.m. NZDT, down 0.41 percent on the session. The latest corporate step is the designation of Leanne Lazarus as CEO designate for the proposed TSB Heartland Bank, announced on October 2, 2026.

Merger leadership takes shape

According to StockWire X on October 2, the Establishment Panel endorsed Lazarus to lead the planned TSB Heartland Bank after the proposed merger. The appointment remains subject to completion of the transaction and non-objection from the Reserve Bank of New Zealand.

The transaction has a stated value of NZD 620 million. Heartland shareholders approved it with 94.8 percent of votes cast on September 30, 2026, clearing the 75 percent special-resolution threshold, according to The Market Floor on October 2.

FY2026 earnings add operating support

Heartland reported FY2026 revenue of NZD 326.12 million, up 29.8 percent from NZD 251.25 million in FY2025. Net income reached NZD 93.23 million, compared with NZD 38.81 million a year earlier, an increase of 140.2 percent, according to Investing.com.

The earnings comparison gives the merger story a stronger financial base, but the transaction still depends on regulatory steps. That makes execution, approval timing and the integration of the two banking operations the central issues for the stock.

Consensus target sits above NZD 1.22

Investing.com lists a Neutral consensus from two analysts, with an average 12-month price target of NZD 1.31, a high target of NZD 1.45 and a low target of NZD 1.17. The average target lies 7.4 percent above the NZD 1.22 reference price.

HGH trades inside its yearly range

HGH was last at NZD 1.22 on the NZX on October 8, 2026 at 4:40 p.m. NZDT, with a 52-week range of NZD 1.01 to NZD 1.30 and market capitalization of NZD 1.3 billion. For investors, the proposed merger now combines a quantified earnings comparison with a leadership decision that still awaits regulatory completion.